End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.1 TWD | +7.89% |
|
+10.68% | -19.91% |
25/04 | Vectorite Biomedical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Vectorite Biomedical Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cellular Products
51.0
%
| 23 | 54.6 % | 29 | 51.0 % | +21.71% |
Formulation
36.4
%
| 12 | 28.1 % | 20 | 36.4 % | +68.81% |
Store
8.1
%
| 5 | 12.0 % | 5 | 8.1 % | -12.54% |
Medical Service
2.5
%
| 1 | 2.0 % | 1 | 2.5 % | +66.78% |
Cell Collection Processing
1.9
%
| 1 | 3.4 % | 1 | 1.9 % | -24.65% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
100.0
%
| 43 | 100.0 % | 56 | 100.0 % | +30.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ming Chang Ou
CEO | Chief Executive Officer | - | 01/17/01 |
Hui Ching Yu
DFI | Director of Finance/CFO | - | 26/20/26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shih Hsing Tsai
BRD | Director/Board Member | - | 01/05/01 |
So Chu Chang
CHM | Chairman | - | 20/19/20 |
Pai Jung Lai
BRD | Director/Board Member | - | 20/19/20 |
Tsung Hsien Yang
BRD | Director/Board Member | - | 15/20/15 |
Chang En Tsai
BRD | Director/Board Member | - | 15/22/15 |
Hsiang Yueh Meng
BRD | Director/Board Member | - | 15/22/15 |
Chien Ming Tang
BRD | Director/Board Member | - | 15/22/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,771,000 | 26,860,374 ( 61.37 %) | 0 | 61.37 % |
Company contact information
Vectorite Biomedical, Inc.
6F-11, 97, Section 1 Xintai 5th Road
221 75, New Taipei
+
http://www.vectorite.com.tw![address Vectorite Biomedical Inc.(4170)](https://cdn.zonebourse.com/static/address/20707455.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-19.91% | 22.96M | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.30% | 26.64B | |
-21.81% | 19.91B | |
-16.96% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- 4170 Stock
- Company Vectorite Biomedical Inc.